Why the study?
Does irbesartan cause acute renal failure in a diabetic patient with stable chronic renal insufficiency?
Does irbesartan cause acute renal failure in a diabetic patient with stable chronic renal insufficiency?
Irbesartan can precipitate irreversible acute renal failure in patients with stable chronic renal insufficiency, highlighting the critical need for careful renal function monitoring when initiating angiotensin II receptor antagonists.
Answers are grounded in this paper and cite their sources.
May signal irreversible renal failure risk with irbesartan in stable diabetic CKD; hypothesis-generating case that leaves broader applicability open.
We report the case of a 78-year-old hypertensive diabetic patient without evidence of renal artery stenosis who had moderate chronic renal insufficiency, which had been stable for several years under low-dose captopril therapy, and who rapidly developed acute renal failure when irbesartan was prescribed. Unfortunately the medication was not stopped promptly and the patient never recovered his basal renal function and had to undergo chronic hemodialysis. This observation emphasizes the importance of a careful monitoring of renal function in patients receiving angiotensin II receptor antagonists.
No takes yet. Share an insight, caveat, or question.
Descombes et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: